These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15923622)

  • 1. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.
    Yart A; Gstaiger M; Wirbelauer C; Pecnik M; Anastasiou D; Hess D; Krek W
    Mol Cell Biol; 2005 Jun; 25(12):5052-60. PubMed ID: 15923622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The parafibromin tumor suppressor protein is part of a human Paf1 complex.
    Rozenblatt-Rosen O; Hughes CM; Nannepaga SJ; Shanmugam KS; Copeland TD; Guszczynski T; Resau JH; Meyerson M
    Mol Cell Biol; 2005 Jan; 25(2):612-20. PubMed ID: 15632063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.
    Lin L; Czapiga M; Nini L; Zhang JH; Simonds WF
    Mol Cancer Res; 2007 Feb; 5(2):183-93. PubMed ID: 17314275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
    Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
    Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA.
    Farber LJ; Kort EJ; Wang P; Chen J; Teh BT
    Mol Carcinog; 2010 Mar; 49(3):215-23. PubMed ID: 19908240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.
    Lin L; Zhang JH; Panicker LM; Simonds WF
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17420-5. PubMed ID: 18987311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
    Hahn MA; Marsh DJ
    Oncogene; 2005 Sep; 24(41):6241-8. PubMed ID: 16116486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A posttranscriptional role for the yeast Paf1-RNA polymerase II complex is revealed by identification of primary targets.
    Penheiter KL; Washburn TM; Porter SE; Hoffman MG; Jaehning JA
    Mol Cell; 2005 Oct; 20(2):213-23. PubMed ID: 16246724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic analysis of Paf1/RNA polymerase II complex mutations reveals connections to cell cycle regulation, protein synthesis, and lipid and nucleic acid metabolism.
    Betz JL; Chang M; Washburn TM; Porter SE; Mueller CL; Jaehning JA
    Mol Genet Genomics; 2002 Oct; 268(2):272-85. PubMed ID: 12395202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Paf1 complex promotes displacement of histones upon rapid induction of transcription by RNA polymerase II.
    Marton HA; Desiderio S
    BMC Mol Biol; 2008 Jan; 9():4. PubMed ID: 18194564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
    Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
    Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of parafibromin expression in a subset of parathyroid adenomas.
    Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
    Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human RNA polymerase II-associated factor complex: dysregulation in cancer.
    Chaudhary K; Deb S; Moniaux N; Ponnusamy MP; Batra SK
    Oncogene; 2007 Nov; 26(54):7499-507. PubMed ID: 17599057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.
    Panicker LM; Zhang JH; Dagur PK; Gastinger MJ; Simonds WF
    Endocr Relat Cancer; 2010 Jun; 17(2):513-24. PubMed ID: 20304979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parafibromin inhibits cancer cell growth and causes G1 phase arrest.
    Zhang C; Kong D; Tan MH; Pappas DL; Wang PF; Chen J; Farber L; Zhang N; Koo HM; Weinreich M; Williams BO; Teh BT
    Biochem Biophys Res Commun; 2006 Nov; 350(1):17-24. PubMed ID: 16989776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Paf1 complex physically and functionally associates with transcription elongation factors in vivo.
    Squazzo SL; Costa PJ; Lindstrom DL; Kumer KE; Simic R; Jennings JL; Link AJ; Arndt KM; Hartzog GA
    EMBO J; 2002 Apr; 21(7):1764-74. PubMed ID: 11927560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Requirement for the Saccharomyces cerevisiae Paf1 complex in snoRNA 3' end formation.
    Sheldon KE; Mauger DM; Arndt KM
    Mol Cell; 2005 Oct; 20(2):225-36. PubMed ID: 16246725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interactions between the Paf1 complex and a cleavage and polyadenylation factor are revealed by dissociation of Paf1 from RNA polymerase II.
    Nordick K; Hoffman MG; Betz JL; Jaehning JA
    Eukaryot Cell; 2008 Jul; 7(7):1158-67. PubMed ID: 18469135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
    Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
    Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.